- Conditions: cUTI; Complicated Urinary Tract Infection; Acute Pyelonephritis
Interventions: Drug: CAZ-AVI; Drug: Doripenem
Sponsors: AstraZeneca; AstraZeneca; Cerexa, Inc.
Not yet recruiting - verified May 2012 - Condition: Hyperlipidemia
Intervention: Drug: Sitagliptin
Sponsors: University Health Network, Toronto; University Health Network, Toronto; Merck Frosst Canada Ltd.
Not yet recruiting - verified April 2012 - Condition: Late Life Depression
Intervention: Drug: Mirtazapine
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute
Not yet recruiting - verified May 2012 - Conditions: Urinary Incontinence; Multiple Sclerosis
Interventions: Biological: OnabotulinumtoxinA; Drug: Placebo (Normal Saline); OnabotulinumtoxinA
Sponsors: Allergan; Allergan
Not yet recruiting - verified May 2012 - Condition: Actinic Keratosis
Interventions: Drug: Ingenol mebutate gel, 0.015%; Drug: Vehicle gel
Sponsors: LEO Pharma; LEO Pharma
Recruiting - verified May 2012 - Conditions: Healthy Infants; Immunization; Pain Management
Intervention: Behavioral: Tactile stimulation
Sponsors: University of Toronto; University of Toronto
Not yet recruiting - verified May 2012 - Condition: Fecal Incontinence
Intervention: Biological: AMDC
Sponsors: Cook; Cook
Recruiting - verified May 2012 - Condition: Multiple Sclerosis
Interventions: Drug: PR Fampridine; Other: Placebo
Sponsors: Biogen Idec; Biogen Idec
Not yet recruiting - verified May 2012 - Condition: Chronic Pain
Intervention: Behavioral: Online ABBT for Chronic Pain in Military
Sponsors: University of Manitoba; University of Manitoba
Not yet recruiting - verified April 2012 - Condition: Spinal Cord Injury
Interventions: Drug: Riluzole; Drug: Placebo; Other: No intervention
Sponsors: SpineNet; SpineNet
Not yet recruiting - verified May 2012 - Condition: Voiding Dysfunction After Pelvic Organ Prolapse Surgery
Intervention: Procedure: CISC instruction pre-operatively
Sponsors: St. Michael's Hospital, Toronto; St. Michael's Hospital, Toronto
Not yet recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Intervention: Behavioral: Lifestyle Counselling
Sponsors: University of Manitoba; University of Manitoba; Manitoba Institute of Child Health
Not yet recruiting - verified May 2012 - Conditions: Probable Migraine; Migraine With Aura; Migraine Without Aura
Interventions: Drug: Ketorolac Tromethamine; Drug: Metoclopramide
Sponsors: University of Alberta; University of Alberta; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified May 2012 - Conditions: Bradycardia; Desaturation
Interventions: Drug: Provision of atropine; Drug: Placebo
Sponsors: University of Manitoba; University of Manitoba
Recruiting - verified May 2012 - Conditions: Depressive Disorder; Schizophrenia; Obsessive-Compulsive Disorder
Intervention: Device: Magnetic Seizure Therapy (MagPro MST)
Sponsors: Centre for Addiction and Mental Health; Centre for Addiction and Mental Health; University Health Network, Toronto
Recruiting - verified May 2012 - Conditions: To Determine the Effects of an ad Libitum Intake of 1%; Milk, Fruit Juice, Regular Soda, Diet Soda and Water, as Part of a Pizza Meal, on Meal Food Intake, Appetite and Postprandial Blood Glucose in Healthy Men and; Women.
Intervention: Other: Nutritional Intervention
Sponsors: University of Toronto; University of Toronto
Active, not recruiting - verified June 2011 - Condition: Injury Prevention
Intervention: Behavioral: Passenger effect
Sponsors: Centre Hospitalier Universitaire de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke
Recruiting - verified May 2012 - Conditions: HER2 + Breast Cancer; HER2 + Gastric Cancer; Squamous Cell Carcinoma of Head and Neck
Intervention: Drug: LJM716
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Condition: Seniors With Mobility Limitations
Interventions: Other: Mobility self-management with Mentor; Other: Mobility self-management with guidebook
Sponsors: McGill University; McGill University; Richard and Edith Strauss Foundation of Canada
Not yet recruiting - verified May 2012 - Conditions: Alcohol Abuse; Drug Abuse; Mood Disorder; Anxiety Disorder; Conduct Disorder
Interventions: Behavioral: Personality-targeted interventions; Behavioral: Personality-targeted interventions; Behavioral: Personality-targeted interventions; Behavioral: Personality-targeted interventions
Sponsors: Université de Montréal; Université de Montréal
Recruiting - verified May 2012 - Condition: Psychomotor Impairment
Interventions: Drug: delta-9-tetrahydrocannabinol; Drug: Placebo
Sponsors: Centre for Addiction and Mental Health; Centre for Addiction and Mental Health; Canadian Institutes of Health Research (CIHR); Health Canada
Not yet recruiting - verified May 2012 - Condition: Branch Retinal Vein Occlusion
Interventions: Drug: Ranibizumab; Procedure: Laser
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Conditions: End Stage Renal Disease; Venous Stenosis
Intervention: Drug: Sirolimus
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; Pfizer
Recruiting - verified May 2012 - Condition: ACL Injury
Intervention: Other: Core-PAC
Sponsors: University of British Columbia; University of British Columbia
Completed - verified May 2012 - Condition: Heterotaxy Syndrome
Intervention:
Sponsors: University of Alberta; University of Alberta
Recruiting - verified May 2012 - Condition: Early-Stage Squamous Cell Carcinoma of the Oropharynx
Interventions: Radiation: Radiotherapy; Procedure: Transoral Robotic Surgery + Neck Dissection
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute
Not yet recruiting - verified May 2012 - Condition: Severe Sepsis
Interventions: Drug: Vitamin C; Drug: placebo
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute
Not yet recruiting - verified May 2012 - Conditions: Dyslipidemia; Diabetes; Prediabetes; Dysglycemia; Overweight; Obesity; Hypertension; Metabolic Syndrome; Cardiovascular Disease
Intervention: Other: Dietary pulses
Sponsors: University of Toronto; University of Toronto; Canadian Institutes of Health Research (CIHR); Canada Research Chair Endowment of the Federal Government of Canada; Canadian Institutes of Health Research (CIHR) Postdoctoral Fellowship Award; Pulse Canada
Active, not recruiting - verified April 2012 - Condition: Prediabetes
Intervention: Behavioral: Lifestyle changes
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified April 2012 - Condition: Type 1 Diabetes
Intervention: Device: Pump suspension
Sponsors: In Home Closed Loop Study Group; In Home Closed Loop Study Group; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified May 2012 - Condition: Familial Chylomicronemia Syndrome (FCS) (HLP Type I)
Intervention: Drug: LCQ908
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified April 2012 - Conditions: Low Anterior Resection Syndrome; Rectal Cancer
Intervention: Drug: intra-rectal Botulinum toxin A injection
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Allergan
Not yet recruiting - verified June 2011 - Condition: Neuroblastoma
Intervention:
Sponsors: New Approaches to Neuroblastoma Therapy Consortium; New Approaches to Neuroblastoma Therapy Consortium
Recruiting - verified April 2012 - Conditions: Gambling; Pathological Gambling
Interventions: Behavioral: Treatment as Usual; Behavioral: Cognitive Motivational Behavior Therapy; Behavioral: 12-week wait list
Sponsors: National Institute on Drug Abuse (NIDA); Ontario Problem Gambling Research Centre; Wayne State University; Windsor Regional Hospital
Recruiting - verified May 2012 - Condition: Respiratory Distress Syndrome
Interventions: Device: Neurally Adjusted Ventilatory Assist (NAVA); Device: SiPAP - placebo
Sponsors: Fraser Health; Fraser Health
Not yet recruiting - verified April 2012 - Condition: Traumatic Intracranial Haemorrhage
Interventions: Drug: Enoxaparin; Other: Placebo
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified April 2012 - Condition: Psoriasis
Interventions: Drug: ustekinumab; Drug: placebo
Sponsors: Centocor Research & Development, Inc.; Centocor Research & Development, Inc.
Completed - verified April 2012 - Condition: Distal Radius Fracture
Interventions: Procedure: Open Reduction and Internal Fixation; Procedure: External Fixation; Procedure: Percutaneous Pinning; Procedure: Closed Reduction and casting
Sponsors: University of Michigan; University of Michigan; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institute on Aging (NIA)
Recruiting - verified May 2012 - Conditions: Influenza, Human; Orthomyxoviridae Infections; RNA Virus Infections; Virus Diseases; Respiratory Tract Infections; Respiratory Tract Diseases
Intervention: Biological: FVH1 - a DNA-based influenza vaccine
Sponsors: University of Manitoba; University of Manitoba; Inovio Pharmaceuticals
Not yet recruiting - verified April 2012 - Condition: Reflex Sympathetic Dystrophy
Intervention:
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute
Recruiting - verified April 2012 - Condition: Shoulder Dislocation
Intervention:
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified April 2012 - Conditions: Cervical Deformity; Kyphosis; Scoliosis
Intervention:
Sponsors: International Spine Study Group Foundation; International Spine Study Group Foundation; DePuy Spine
Enrolling by invitation - verified April 2012 - Condition: Psoriasis
Interventions: Drug: ASKP1240; Drug: Placebo
Sponsors: Astellas Pharma Inc; Astellas Pharma Global Development, Inc.; Kyowa Hakko Kirin Company, Limited
Recruiting - verified April 2012 - Condition: Bipolar Depression
Interventions: Device: Magstim Rapid2 Stimulator; Device: Magstim Rapid2 Stimulator
Sponsors: Douglas Mental Health University Institute; Douglas Mental Health University Institute
Not yet recruiting - verified April 2012 - Condition: Coronary Artery Disease
Interventions: Procedure: LIMA to SVG Bridge Technique; Procedure: Conventional CABG
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM)
Not yet recruiting - verified April 2012 - Condition: Metastatic Pancreas Cancer
Interventions: Drug: 5FU, leucovorin, oxaliplatin; Drug: Gemcitabine
Sponsors: Alberta Health Services; Alberta Health Services
Not yet recruiting - verified April 2012 - Conditions: Heart Failure; Type 2 Diabetes; Glucose Intolerance
Interventions: Drug: Eplerenone; Drug: Spironolactone
Sponsors: Montreal Heart Institute; Montreal Heart Institute; Pfizer
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis (RA)
Interventions: Other: DAS28-IOMS; Other: 0SJ-IOMS; Other: Routine Care (RC)
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; Abbott
Completed - verified April 2012 - Condition: Influenza
Intervention:
Sponsors: University of Alberta; University of Alberta
Not yet recruiting - verified April 2012 - Condition: Upper Respiratory Infections
Intervention: Drug: IFF flavor 316 282, Paracetamol, Pseudoephedrine
Sponsors: Novartis; Novartis; Novartis Consumer Health
Not yet recruiting - verified April 2012 - Conditions: Spinal Cord Injuries; Muscle Spasticity
Intervention:
Sponsors: University of Alberta; University of Alberta
Recruiting - verified April 2012 - Condition: Ankylosing Spondyloarthritis
Interventions: Drug: Apremilast tablet 20 mg; Drug: Apremilast tablet 30 mg BID; Drug: Placebo
Sponsors: Celgene Corporation; Celgene Corporation
Recruiting - verified May 2012 - Condition: Blood Coagulation Disorders
Intervention: Drug: Dabigatran Etexilate 110 mg
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Capital Health, Canada; Dalhousie University; Université de Montréal
Not yet recruiting - verified April 2012 - Condition: Vitamin B12 Deficiency
Interventions: Dietary Supplement: L-5-methyltetrahydrofolate (Metafolin ®); Dietary Supplement: folic acid; Dietary Supplement: Placebo
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified April 2012 - Conditions: Lung Cancer; Breathlessness
Intervention: Behavioral: Self-management Intervention
Sponsors: University Health Network, Toronto; University Health Network, Toronto; National Lung Cancer Partnership; Oncology Nursing Society Foundation; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified April 2012 - Condition: Quality of Life
Intervention: Behavioral: Workout based on active video gaming
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Novartis Pharmaceuticals
Not yet recruiting - verified March 2012 - Condition: Prostate Cancer
Intervention: Radiation: focal salvage HDR prostate brachytherapy
Sponsors: Sunnybrook Health Sciences Centre; Sunnybrook Health Sciences Centre; Canadian Association of Radiation Oncology
Not yet recruiting - verified April 2012 - Condition: Gestational Diabetes Mellitus
Interventions: Other: Low GI diet; Other: Standard Care
Sponsors: University of Toronto; University of Toronto; Canadian Diabetes Association; Canadian Institutes of Health Research (CIHR); Canadian Foundation for Dietetic Research (CFDR)
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: MEMP1972A; Drug: MEMP1972A; Drug: MEMP1972A; Drug: placebo
Sponsors: Genentech; Genentech
Not yet recruiting - verified April 2012 - Condition: Bipolar Disorder
Interventions: Drug: Bupropion; Device: Repetitive Transcranial Magnetic Stimulation; Other: Placebo
Sponsors: McGill University Health Center; McGill University Health Center
Not yet recruiting - verified April 2012 - Condition: Vestibulodynia
Intervention: Behavioral: Cognitive-behavioral couple therapy (CBCT)
Sponsors: Université de Montréal; Université de Montréal
Not yet recruiting - verified May 2012 - Condition: Hepatitis C
Intervention: Drug: Boceprevir
Sponsors: University of Calgary; University of Calgary; Merck
Not yet recruiting - verified April 2012 - Condition: Acute Respiratory Distress Syndrome
Intervention:
Sponsors: Canadian Critical Care Trials Group; Canadian Critical Care Trials Group; Canadian Intensive Care Foundation
Recruiting - verified April 2012 - Condition: Patients Discharged From General Internal Medicine.
Intervention:
Sponsors: Mount Sinai Hospital, Canada; Mount Sinai Hospital, Canada
Not yet recruiting - verified April 2012
 |
Paid Clinical Trials in Canada |
Clinical Trial Locations 